A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Phototoxic Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers.

Trial Profile

A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Phototoxic Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Jun 2017

At a glance

  • Drugs Tazarotene (Primary)
  • Indications Acne; Photodamage; Psoriasis
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Nov 2010 Status changed from active, no longer recruiting to completed.
    • 06 Aug 2010 Actual patient number is 38 according to ClinicalTrials.gov.
    • 06 Aug 2010 Planned end date changed from 1 Jun 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top